IMRT boost dose planning on dominant intraprostatic lesions: Gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI

This publication has 47 references indexed in Scilit:

• Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization
  International Journal of Radiation Oncology*Biology*Physics, 2005
• Dynamic contrast‐enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI
  Magnetic Resonance in Medicine, 2005
• Combined quantitative dynamic contrast‐enhanced MR imaging and ¹H MR spectroscopic imaging of human prostate cancer
  Journal of Magnetic Resonance Imaging, 2004
• Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Prostate Cancer Radiotherapy Dose Response: An Update of the Fox Chase Experience
  Journal of Urology, 2004
• The Use of Rectal Balloon During the Delivery of Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer
  The Cancer Journal, 2002
• Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy
  Urology, 1995
• A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density
  Physics in Medicine & Biology, 1993
• Complication Probability as Assessed from Dose-Volume Histograms
  Radiation Research, 1985